PDF(Pubmed)
Abstract：
UNASSIGNED: Death anxiety and maladaptive coping accompany breast cancer diagnoses. The coping mechanisms and death anxiety among Palestinian patients with breast cancer have not been studied.
UNASSIGNED: To assess the prevalence of death anxiety and its relationship with coping strategies among Palestinian women with breast cancer who are treated in Beit Jala Governmental Hospital in Bethlehem.
UNASSIGNED: A cross-sectional design was used, and 214 breast cancer patients who visited the Beit Jala Governmental Hospital in Bethlehem were recruited. Templer\'s Death Anxiety Scale and the Brief COPE Scale were used. To investigate the relationship between coping strategies and death anxiety, frequency, percentages, chi-square tests, and Pearson\'s correlation tests were utilized.
UNASSIGNED: The results indicated that 58.40% of the patients experienced death anxiety. The participants who used positive reframing (adjusted odds ratio (AOR) = 1.487, p = < 0.026), self-blame (AOR = 1.309, p = < 0.023), and religion (AOR = 1.260, p = < 0.031) as coping mechanisms were more likely to experience death anxiety. Conversely, the participants who adopted substance use (AOR = 0.657, p < 0.005) and active coping (AOR = 0.629, p < 0.007) as coping strategies had a lower likelihood of experiencing death anxiety.
UNASSIGNED: The study revealed that breast cancer patients tended to use a combination of functional and emotional coping strategies and that a significant proportion of these patients (58.4%) experienced symptoms of death anxiety. This study emphasizes the significance of screening for death anxiety and understanding the coping strategies utilized by the patients. Gaining this understanding will assist in identifying patients who need more guidance and support.
UNASSIGNED: To assess the prevalence of death anxiety and its relationship with coping strategies among Palestinian women with breast cancer who are treated in Beit Jala Governmental Hospital in Bethlehem.
UNASSIGNED: A cross-sectional design was used, and 214 breast cancer patients who visited the Beit Jala Governmental Hospital in Bethlehem were recruited. Templer\'s Death Anxiety Scale and the Brief COPE Scale were used. To investigate the relationship between coping strategies and death anxiety, frequency, percentages, chi-square tests, and Pearson\'s correlation tests were utilized.
UNASSIGNED: The results indicated that 58.40% of the patients experienced death anxiety. The participants who used positive reframing (adjusted odds ratio (AOR) = 1.487, p = < 0.026), self-blame (AOR = 1.309, p = < 0.023), and religion (AOR = 1.260, p = < 0.031) as coping mechanisms were more likely to experience death anxiety. Conversely, the participants who adopted substance use (AOR = 0.657, p < 0.005) and active coping (AOR = 0.629, p < 0.007) as coping strategies had a lower likelihood of experiencing death anxiety.
UNASSIGNED: The study revealed that breast cancer patients tended to use a combination of functional and emotional coping strategies and that a significant proportion of these patients (58.4%) experienced symptoms of death anxiety. This study emphasizes the significance of screening for death anxiety and understanding the coping strategies utilized by the patients. Gaining this understanding will assist in identifying patients who need more guidance and support.
摘要：
■乳腺癌诊断伴随着死亡焦虑和适应不良应对。巴勒斯坦乳腺癌患者的应对机制和死亡焦虑尚未研究。
■评估在伯利恒BeitJala政府医院接受治疗的巴勒斯坦乳腺癌妇女中死亡焦虑的患病率及其与应对策略的关系。
■使用了横截面设计，并招募了214名在伯利恒BeitJala政府医院就诊的乳腺癌患者。使用Templer的死亡焦虑量表和简短的COPE量表。探讨应对策略与死亡焦虑的关系,频率,百分比,卡方检验,并利用皮尔逊的相关性检验。
■结果显示58.40%的患者出现死亡焦虑。使用正重构的参与者(调整后优势比(AOR)=1.487，p=<0.026)，自责(AOR=1.309，p=<0.023)，和宗教（AOR=1.260，p=<0.031）作为应对机制更容易经历死亡焦虑。相反，采用物质使用(AOR=0.657,p<0.005)和积极应对(AOR=0.629,p<0.007)作为应对策略的参与者出现死亡焦虑的可能性较低.
■研究表明，乳腺癌患者倾向于使用功能和情绪应对策略的组合，并且这些患者中有很大一部分（58.4％）出现了死亡焦虑症状。这项研究强调了筛查死亡焦虑和了解患者使用的应对策略的重要性。获得这种理解将有助于识别需要更多指导和支持的患者。
■评估在伯利恒BeitJala政府医院接受治疗的巴勒斯坦乳腺癌妇女中死亡焦虑的患病率及其与应对策略的关系。
■使用了横截面设计，并招募了214名在伯利恒BeitJala政府医院就诊的乳腺癌患者。使用Templer的死亡焦虑量表和简短的COPE量表。探讨应对策略与死亡焦虑的关系,频率,百分比,卡方检验,并利用皮尔逊的相关性检验。
■结果显示58.40%的患者出现死亡焦虑。使用正重构的参与者(调整后优势比(AOR)=1.487，p=<0.026)，自责(AOR=1.309，p=<0.023)，和宗教（AOR=1.260，p=<0.031）作为应对机制更容易经历死亡焦虑。相反，采用物质使用(AOR=0.657,p<0.005)和积极应对(AOR=0.629,p<0.007)作为应对策略的参与者出现死亡焦虑的可能性较低.
■研究表明，乳腺癌患者倾向于使用功能和情绪应对策略的组合，并且这些患者中有很大一部分（58.4％）出现了死亡焦虑症状。这项研究强调了筛查死亡焦虑和了解患者使用的应对策略的重要性。获得这种理解将有助于识别需要更多指导和支持的患者。
